• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Contrast-induced nephropathy; A literature review.对比剂肾病:文献综述
J Nephropathol. 2014;3(2):51-6. doi: 10.12860/jnp.2014.12. Epub 2014 Apr 1.
2
Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗中对比剂诱导肾病的预防:系统评价。
J Interv Cardiol. 2013 Feb;26(1):97-105. doi: 10.1111/joic.12007. Epub 2012 Dec 13.
3
Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.等渗与低渗对比剂对低风险患者的肾毒性相当。
Clin Nephrol. 2006 Nov;66(5):322-30. doi: 10.5414/cnp66322.
4
Evaluating the Effectiveness of Pretreatment With Intravenous Fluid in Reducing the Risk of Developing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis.评估静脉输液预处理在降低对比剂诱导的肾病发生风险中的有效性:一项系统评价和荟萃分析。
Cureus. 2022 May 8;14(5):e24825. doi: 10.7759/cureus.24825. eCollection 2022 May.
5
The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction.等渗对比剂在ST段抬高型心肌梗死急诊经皮冠状动脉介入治疗中的应用影响。
J Invasive Cardiol. 2011 Nov;23(11):448-50.
6
Current concepts of contrast-induced nephropathy: a brief review.当前对比剂诱导肾病的概念:简要综述。
J Chin Med Assoc. 2013 Dec;76(12):673-81. doi: 10.1016/j.jcma.2013.08.011. Epub 2013 Oct 3.
7
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.离子型低渗与非离子型等渗对比剂在慢性肾衰竭患者血管成形术后避免肾功能恶化的比较:ICON(离子型与非离子型对比剂在慢性肾衰竭患者血管成形术后避免肾功能恶化的研究)。
JACC Cardiovasc Interv. 2009 May;2(5):415-21. doi: 10.1016/j.jcin.2009.03.007.
8
Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.加拿大放射学会:预防对比剂肾病的共识指南
Can Assoc Radiol J. 2007 Apr;58(2):79-87.
9
Contrast-induced nephropathy.对比剂肾病
Eur Radiol. 2005 Nov;15 Suppl 4:D65-9. doi: 10.1007/s10406-005-0113-x.
10
Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.等渗和低渗造影剂给药后的肾病:网状荟萃分析证据
Int J Cardiol. 2014 Mar 15;172(2):375-80. doi: 10.1016/j.ijcard.2014.01.075. Epub 2014 Jan 24.

引用本文的文献

1
A narrative review on adverse drug reactions of COVID-19 treatments on the kidney.关于新冠病毒疾病治疗药物对肾脏不良反应的叙述性综述。
Open Med (Wars). 2024 Mar 15;19(1):20230867. doi: 10.1515/med-2023-0867. eCollection 2024.
2
Association of N-acetylcysteine use with contrast-induced nephropathy: an umbrella review of meta-analyses of randomized clinical trials.N-乙酰半胱氨酸的使用与对比剂诱导的肾病的关联:随机临床试验荟萃分析的伞形综述
Front Med (Lausanne). 2023 Sep 14;10:1235023. doi: 10.3389/fmed.2023.1235023. eCollection 2023.
3
Potential therapeutic effects of Chinese meteria medica in mitigating drug-induced acute kidney injury.中药在减轻药物性急性肾损伤中的潜在治疗作用。
Front Pharmacol. 2023 Apr 3;14:1153297. doi: 10.3389/fphar.2023.1153297. eCollection 2023.
4
Is It Safe to Do Percutaneous Coronary Intervention in Moderate to Severe Chronic Kidney Disease Patients? A Prospective Cohort Study.对中重度慢性肾脏病患者进行经皮冠状动脉介入治疗是否安全?一项前瞻性队列研究。
Cureus. 2022 Oct 14;14(10):e30312. doi: 10.7759/cureus.30312. eCollection 2022 Oct.
5
Incidence of Contrast-Associated Acute Kidney Injury in Renal-Competent COVID-19 Patients Undergoing Computed Chest Angiography.肾功能正常的 COVID-19 患者行计算机胸部血管造影检查后对比剂相关急性肾损伤的发生率。
J Comput Assist Tomogr. 2022;46(5):701-706. doi: 10.1097/RCT.0000000000001337. Epub 2022 Jun 3.
6
Retracted Article: High-throughput metabolomics identifies serum metabolic signatures in acute kidney injury using LC-MS combined with pattern recognition approach.撤稿文章:高通量代谢组学结合模式识别方法利用液相色谱-质谱联用技术鉴定急性肾损伤的血清代谢特征。
RSC Adv. 2018 Apr 18;8(27):14838-14847. doi: 10.1039/c8ra01749b.
7
Predialysis serum lactate levels could predict dialysis withdrawal in Type 1 cardiorenal syndrome patients.透析前血清乳酸水平可预测1型心肾综合征患者的透析撤机情况。
EClinicalMedicine. 2022 Jan 10;44:101232. doi: 10.1016/j.eclinm.2021.101232. eCollection 2022 Feb.
8
Calorie Restriction Protects against Contrast-Induced Nephropathy via SIRT1/GPX4 Activation.热量限制通过 SIRT1/GPX4 激活来预防对比剂诱导的肾病。
Oxid Med Cell Longev. 2021 Oct 19;2021:2999296. doi: 10.1155/2021/2999296. eCollection 2021.
9
Heat Shock Protein 27 Is an Emerging Predictor of Contrast-Induced Acute Kidney Injury on Patients Subjected to Percutaneous Coronary Interventions.热休克蛋白 27 是经皮冠状动脉介入治疗患者对比剂诱导急性肾损伤的新兴预测因子。
Cells. 2021 Mar 19;10(3):684. doi: 10.3390/cells10030684.
10
Kidney Injury Molecule-1 Is Associated with Contrast-Induced Nephropathy in Elderly Patients with Non-STEMI.肾损伤分子-1 与非 ST 段抬高型心肌梗死老年患者对比剂肾病相关。
Arq Bras Cardiol. 2021 Jun;116(6):1048-1056. doi: 10.36660/abc.20200172.

本文引用的文献

1
Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment.经皮冠状动脉介入治疗中对比剂肾病:发病机制、危险因素、预后、预防及治疗
Cardiology. 2014;128(1):62-72. doi: 10.1159/000358042. Epub 2014 Feb 18.
2
Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy.识别和水化高危住院患者对比剂肾病的指南遵循情况。
BMC Nephrol. 2014 Jan 6;15:2. doi: 10.1186/1471-2369-15-2.
3
Contrast-induced nephropathy: pathophysiology and preventive strategies.对比剂肾病:病理生理学与预防策略
Crit Care Nurse. 2013 Feb;33(1):37-46. doi: 10.4037/ccn2013680.
4
N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review.N-乙酰半胱氨酸预防对比剂肾病:叙事性综述。
Korean Circ J. 2011 Dec;41(12):695-702. doi: 10.4070/kcj.2011.41.12.695. Epub 2011 Dec 31.
5
Influence of the timing of cardiac catheterization and amount of contrast media on acute renal failure after cardiac surgery.心脏导管插入术时机及造影剂用量对心脏手术后急性肾衰竭的影响。
J Res Med Sci. 2011 Apr;16(4):502-8.
6
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.对比剂管理后肾功能不全试验 II(REMEDIAL II):肾保护系统在高危对比剂诱导急性肾损伤患者中的应用。
Circulation. 2011 Sep 13;124(11):1260-9. doi: 10.1161/CIRCULATIONAHA.111.030759. Epub 2011 Aug 15.
7
Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis.使用N-乙酰半胱氨酸减少心胸外科手术后并发症:一项荟萃分析。
Eur J Cardiothorac Surg. 2009 Mar;35(3):521-7. doi: 10.1016/j.ejcts.2008.11.027. Epub 2009 Jan 14.
8
Contrast agents and renal cell apoptosis.造影剂与肾细胞凋亡
Eur Heart J. 2008 Oct;29(20):2569-76. doi: 10.1093/eurheartj/ehn197. Epub 2008 May 8.
9
Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.对比剂肾病:定义、发病率、转归、病理生理学、危险因素及预防
Minerva Med. 2008 Apr;99(2):177-96.
10
A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.经皮冠状动脉介入治疗患者中对比剂肾病当代定义的比较及一种新型肾病分级系统的提议。
Am J Cardiol. 2008 Mar 15;101(6):812-9. doi: 10.1016/j.amjcard.2007.10.051. Epub 2008 Jan 14.

对比剂肾病:文献综述

Contrast-induced nephropathy; A literature review.

作者信息

Golshahi Jafar, Nasri Hamid, Gharipour Mojgan

机构信息

Department of Cardiology, Isfahan University of Medical Sciences, Isfahan, Iran.

Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

J Nephropathol. 2014;3(2):51-6. doi: 10.12860/jnp.2014.12. Epub 2014 Apr 1.

DOI:10.12860/jnp.2014.12
PMID:24772397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3999584/
Abstract

CONTEXT

Contrast-induced nephropathy (CIN) is a common cause of acute kidney dysfunction.

EVIDENCE ACQUISITIONS

Directory of Open Access Journals, Google Scholar, PubMed, EBSCO and Web of Science have been searched.

RESULTS

It is necessary to identify at risk patients at early stages to implement preventive strategies to decrease the incidence of this nephropathy. However, mechanisms of CIN have not fully explained yet. It seems that mechanisms which mediated by nitric oxide and prostaglandin-induced vasodilatation have been played a crucial role in the CIN. Hemodynamic changes of renal blood flow, which causes hypoxia in the renal medulla and direct toxic effects of contrast media on renal cells, are thought to contribute to the pathogenesis of CIN. Contrast media is normally divided into iso-osmolar, low-osmolar, and high-osmolar. N-acetylcysteine is considered as one of the best choices to prevent CIN in high-risk groups.

CONCLUSIONS

The first aim to prevent CIN is identifying high-risk subjects and controlling associate risk factors. As significant differences existed between contrasts agents due to their physicochemical properties, low-osmolar or iso-osmolar contrast media should be used to prevent CIN in at-risk patients. The volume of contrast media should be as low as possible.

摘要

背景

对比剂肾病(CIN)是急性肾功能不全的常见原因。

证据收集

检索了开放获取期刊目录、谷歌学术、PubMed、EBSCO和科学网。

结果

有必要在早期识别高危患者,以实施预防策略,降低这种肾病的发生率。然而,CIN的机制尚未完全阐明。似乎由一氧化氮和前列腺素诱导的血管舒张介导的机制在CIN中起关键作用。肾血流的血流动力学变化导致肾髓质缺氧以及对比剂对肾细胞的直接毒性作用,被认为是CIN发病机制的原因。对比剂通常分为等渗、低渗和高渗。N-乙酰半胱氨酸被认为是预防高危人群CIN的最佳选择之一。

结论

预防CIN的首要目标是识别高危人群并控制相关危险因素。由于对比剂的物理化学性质存在显著差异,应使用低渗或等渗对比剂来预防高危患者发生CIN。对比剂的用量应尽可能低。